Verena Sailer

1.3k total citations
34 papers, 715 citations indexed

About

Verena Sailer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Verena Sailer has authored 34 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Verena Sailer's work include Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Epigenetics and DNA Methylation (7 papers). Verena Sailer is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Epigenetics and DNA Methylation (7 papers). Verena Sailer collaborates with scholars based in Germany, United States and Austria. Verena Sailer's co-authors include Glen Kristiansen, Dimo Dietrich, Barbara Uhl, Sebastian Meller, Emily Eva Holmes, Maria Jung, Sven Perner, Anne Offermann, Jutta Kirfel and Axel S. Merseburger and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Verena Sailer

31 papers receiving 702 citations

Peers

Countries citing papers authored by Verena Sailer

Since Specialization

Citations

This map shows the geographic impact of Verena Sailer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Sailer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Sailer more than expected).

Fields of papers citing papers by Verena Sailer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Sailer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Sailer. The network helps show where Verena Sailer may publish in the future.

Co-authorship network of co-authors of Verena Sailer

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Sailer. A scholar is included among the top collaborators of Verena Sailer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Sailer. Verena Sailer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CEACAM6 Promotes Lung MetastasisviaEnhancing Proliferation, Migration and Suppressing Apoptosis of Prostate Cancer Cells 2024 ·Cancer Genomics & Proteomics ·(unknown), (unknown), (unknown), (unknown), Anne Offermann, (unknown), Danny Jonigk, Mark Kühnel, Sven Perner, Jutta Kirfel, Verena Sailer	0
2	Comprehensive transcriptomic analysis of prostate cancer lung metastases 2024 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Anne Offermann, Danny Jonigk, Mark Kuehnel, Jutta Kirfel, Sven Perner, Verena Sailer	0
3	Elevated PSPC1 and KDM5C expression indicates poor prognosis in prostate cancer 2023 ·Human Pathology ·(unknown), (unknown), (unknown), Sven Perner, Verena Sailer, Anne Offermann, Jutta Kirfel	3
4	TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC 2023 ·International Journal of Molecular Sciences ·(unknown), Julika Ribbat‐Idel, (unknown), (unknown), Dirk Rades, Anke Leichtle, Ralph Pries, Karl‐Ludwig Bruchhage, Sven Perner, Anne Offermann, Verena Sailer, Christian Idel	6
5	Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer 2022 ·American Journal Of Pathology ·Anne Offermann, (unknown), (unknown), (unknown), (unknown), (unknown), Lars Tharun, Jochen Behrends, Axel S. Merseburger, Zoran Čulig, Verena Sailer, Johannes Brägelmann, Jutta Kirfel, Sven Perner	7
6	Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker 2022 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Anne Offermann, (unknown), (unknown), Doris Roth, (unknown), Rainer Kuefer, Verena Sailer, Jutta Kirfel, Axel S. Merseburger, Sven Perner	4
7	CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia 2021 ·Human Pathology ·Anne Offermann, (unknown), Marie C. Hupe, (unknown), (unknown), Johannes Brägelmann, Jutta Kirfel, Axel S. Merseburger, Verena Sailer, Lars Tharun, Sven Perner	3
8	International real-world study of DLL3 expression in patients with small cell lung cancer 2020 ·Lung Cancer ·Federico Rojo, Marcelo Corassa, Dimitriοs Mavroudis, Büğe Öz, Bonne Biesma, Luka Brčić, Patrick Pauwels, Verena Sailer, John R. Gosney, Darko Miljkovic, Carlos Hader, Meijing Wu, (unknown), Frédérique Penault‐Llorca	42
9	Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays 2019 ·Laboratory Investigation ·Markus Eckstein, Verena Sailer, Boye Schnack Nielsen, Thomas Wittenberg, Veit Wiesmann, Verena Lieb, Elke Nolte, Arndt Hartmann, Glen Kristiansen, Nicolas Wernert, Bernd Wullich, Helge Täubert, Sven Wach	13
10	The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature 2019 ·World Journal of Urology ·Anne Offermann, Marie C. Hupe, Verena Sailer, Axel S. Merseburger, Sven Perner	13
11	Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer 2019 ·International Journal of Cancer ·(unknown), (unknown), Marie C. Hupe, Doris Roth, Rosemarie Krupar, (unknown), Rainer Kuefer, Verena Sailer, Stefan Duensing, Jutta Kirfel, Axel S. Merseburger, Johannes Brägelmann, Sven Perner, Anne Offermann	25
12	DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients’ survival, immune cell infiltrates, mutational load, and interferon γ signature 2019 ·EBioMedicine ·Verena Sailer, (unknown), Emma Bawden, Romina Zarbl, Constanze Wiek, Timo Vogt, (unknown), (unknown), (unknown), Marieta Toma, Carsten Golletz, Andreas O. H. Gerstner, Glen Kristiansen, Friedrich Bootz, Kathrin Scheckenbach, Jennifer Landsberg, Dimo Dietrich	27
13	Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis 2018 ·Frontiers in Oncology ·Marie C. Hupe, (unknown), Doris Roth, Christiane Kümpers, Julika Ribbat‐Idel, (unknown), (unknown), Stefan Duensing, (unknown), Jutta Kirfel, Verena Sailer, Rainer Kuefer, Axel S. Merseburger, Sven Perner, Anne Offermann	115
14	Prognostic Significance and Functional Role of CEP57 in Prostate Cancer 2015 ·Translational Oncology ·(unknown), Nina Korzeniewski, Dimo Dietrich, Verena Sailer, Yanis Tolstov, (unknown), Jost von Hardenberg, Sven Perner, Glen Kristiansen, Alexander Marx, Wilfried Roth, Esther Herpel, Carsten Grüllich, Ionel Valentin Popeneciu, Sascha Pahernik, Boris Hadaschik, Markus Hohenfellner, Stefan Duensing	9
15	PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer 2015 ·Oncogene ·Martin Puhr, Julia Hoefer, Andrea Eigentler, Dimo Dietrich, Geert van Leenders, Barbara Uhl, (unknown), Florian Handle, Bettina Schlick, Hannes Neuwirt, Verena Sailer, Glen Kristiansen, Helmut Klocker, Zoran Čulig	39
16	Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine 2014 ·PLoS ONE ·Emily Eva Holmes, Maria Jung, Sebastian Meller, (unknown), Verena Sailer, (unknown), (unknown), Leif‐Alexander Garbe, Barbara Uhl, Glen Kristiansen, Dimo Dietrich	104
17	Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia 2014 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sebastian Meller, Anne Bicker, M. Montani, Kristian Ikenberg, (unknown), Verena Sailer, Peter J. Wild, Dimo Dietrich, Barbara Uhl, Tullio Sulser, Holger Moch, Thomas A. Gorr, Carsten Stephan, Klaus Jung, Thomas Hankeln, Glen Kristiansen	24
18	Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition 2013 ·PLoS ONE ·Dimo Dietrich, Barbara Uhl, Verena Sailer, Emily Eva Holmes, Maria Jung, Sebastian Meller, Glen Kristiansen	102
19	Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis 2013 ·Journal of Hepatology ·Silvia Ribback, Diego F. Calvisi, Antonio Cigliano, Verena Sailer, (unknown), (unknown), Claus-Dieter Heidecke, M. Birth, Frank Dombrowski	23
20	Toxoplasmosis after allogeneic stem cell transplantation—a single centre experience 2012 ·Annals of Hematology ·Christoph Busemann, Silvia Ribback, Kathrin Zimmermann, Verena Sailer, Thomas Kiefer, Christian A. Schmidt, Katrin Schulz, Ivo Steinmetz, Frank Dombrowski, Gottfried Dölken, William Krüger	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact